Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

3.7K
3.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Chromatin Structure and RNA Splicing02:41

Chromatin Structure and RNA Splicing

2.7K
2.7K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancer RNAs: similarities with both lncRNAs and mRNAs reveal novel functions.

RNA biology·2026
Same author

Multiple human enhancer RNAs contain long translated open reading frames.

Genes & development·2025
Same author

SUGP1 loss drives SF3B1 hotspot mutant missplicing in cancer.

Cell reports·2025
Same author

Multiple human enhancer RNAs contain long translated open reading frames.

bioRxiv : the preprint server for biology·2025
Same author

Cancer-associated SF3B1 mutation K700E causes widespread changes in U2/branchpoint recognition without altering splicing.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Protocol for detection of cGAMP-induced STING oligomerization in cultured cells.

STAR protocols·2025

Related Experiment Video

Updated: Jun 3, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

8.9K

SF3B1: from core splicing factor to oncogenic driver.

Pedro Bak-Gordon1, James L Manley2

  • 1Department of Biological Sciences, Columbia University, New York, New York 10027, USA.

RNA (New York, N.Y.)
|January 8, 2025
PubMed
Summary
This summary is machine-generated.

Highly recurrent SF3B1 mutations drive cancer by disrupting pre-mRNA splicing. Aberrant splicing of specific transcripts promotes cancer initiation and progression, offering therapeutic targets.

Keywords:
RNA splicing; branchsiteSF3B1SUGP1cancer

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

14.9K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.7K

Related Experiment Videos

Last Updated: Jun 3, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

8.9K
Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

14.9K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.7K

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • RNA Splicing

Background:

  • Somatic mutations in SF3B1, a core splicing factor, are prevalent drivers across various cancer types.
  • SF3B1 functions as a scaffold protein, crucial for spliceosome assembly and accurate pre-mRNA splicing, particularly branchsite recognition.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which oncogenic SF3B1 mutations disrupt splicing.
  • To discuss the role of SF3B1-mutant-specific aberrant splicing in cancer initiation and progression.
  • To highlight the prognostic significance of SF3B1 mutations for targeted therapy development.

Main Methods:

  • Review of molecular mechanisms underlying SF3B1-mediated splicing disruption.
  • Analysis of transcriptomic alterations in SF3B1-mutant cancer cells.
  • Correlation of SF3B1 mutation status with cancer phenotypes and prognosis.

Main Results:

  • SF3B1 mutations perturb early spliceosomal complexes, leading to alternative branchpoint activation and cryptic 3' splice site selection.
  • Aberrantly spliced transcripts in SF3B1-mutant cancers contribute to tumorigenesis.
  • Distinct SF3B1 mutations correlate with specific disease phenotypes and prognostic outcomes.

Conclusions:

  • Understanding SF3B1's role in splicing disruption is key to comprehending its oncogenic potential.
  • Targeting SF3B1-mutant-specific splicing defects presents a promising therapeutic strategy.
  • Further research into SF3B1 mutation-driven cancer biology is critical for clinical advancements.